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Recruitment of proteins to modulate protein-protein interactions 
Jun 0 Liu 
The use of a ‘borrowed’ protein surface to either 
enhance or inhibit the interaction of a small ligand with 
its protein target has been reported recently. This 
approach represents a general method for modulating 
protein-protein interactions and may find many 
applications in both biology and medicine. 
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Protein-protein interactions are involved in the regulation 
of almost all physiological processes, including signal trans- 
duction and transcription. Biologists and chemists have 
long been interested in finding general methods to disrupt 
or enhance interactions between proteins to modulate cel- 
lular processes and to discover new drug candidates. Sig- 
nificant difficulties have been encountered, however, for 
reasons that in retrospect seem obvious. Protein-protein 
interactions rarely rely upon individual amino acid 
residues. Instead, they are often mediated by many amino 
acid residues spread around a large surface, which compli- 
cates the use of small molecules to regulate such interac- 
tions. The interaction of SH2 domains with their 
phosphotyrosine-containing ligands involves only 4-5 
amino acids [l], but, even when so few amino acids are 
involved, finding small molecular antagonists with high 
affinity and specificity is not a straightforward process. 
Nature has encountered and found a way to overcome 
this problem. The immune system recognizes antigens 
through the binding of peptides derived from the invad- 
ing viruses or bacteria to the major histocompatibility 
complex (MHC) protein. The peptide-MHC complex is 
then recognized by the T-cell antigen receptor (TCR), 
triggering T-cell activation. Although the peptide antigen 
cannot bind to the TCR with appreciable affinity, the 
peptide-MHC complex is capable of high-affinity 
binding to the TCR [‘Z]. An even more striking example is 
provided by the unique mode of action of a family of 
immunosuppressive natural products including cyclo- 
sporin A (CsA), FK506 and rapamycin. These natural 
products cannot bind to their respective targets alone. 
Once inside the cell, these compounds bind to abundant 
intracellular immunophilin receptors- cyclophilin (in 
the case of CsA) or FKBP (for FK506 and rapamycin). 
The cyclophilin-CsA and FKBP-FK506 complexes bind 
and inhibit the phosphatase activity of calcineurin [3] 
and the FKBP-rapamycin complex inhibits the kinase 
known as FRAP/RAFT/RAPT/TOR [4-71. A family of 
man-made dimeric immunophilin ligands, known as 
chemical inducers of dimerization, have already found 
widespread use in the modulation of various cellular 
processes and have great potential in gene therapy [S-9]. 
More recently, it was reported that another natural 
product, brefeldin A, may work in a similar fashion. 
Brefeldin A inhibits the activity of the GTP/GDP 
exchange factor for the ADP-ribosylation factor (ARF) by 
trapping the complex formed between the exchange 
factor and the GDP-bound form of ARF, although it 
remains to be determined whether the relatively small 
brefeldin A simultaneously interacts with both proteins 
[lO,ll]. These examples suggest that small molecules 
need not act alone to exert their biological effects but 
can recruit other binding proteins for help to achieve 
high-affinity and high-specificity interactions with a 
given protein target. It is likely that there are other 
ligands yet to be identified that work in a similar fashion. 
Inspired by the unique mode of action of CsA, FK506 and 
rapamycin, Crabtree, Wandless and colleagues [12] came 
upon the idea of using a bifunctional ligand dimer to 
‘borrow’ the surface of immunophilins to alter the affinity 
of the interaction between a given ligand and its target. 
The protein target they chose was the SH2 domain from 
the protein tyrosine kinase Fyn. SH2 domains, one of the 
most widely studied protein modules, are involved in the 
recognition of phosphotyrosine-containing sequences 
present in many signaling proteins [13]. These domains 
are responsible for mediating protein-protein interactions 
in response to the activation of protein tyrosine kinases. 
As a result, SHZ domains from various signaling proteins 
have been popular targets for drug discovery. The SHZ 
domain of Fyn binds to phosphotyrosine-containing pep- 
tides such as pYEE1 [l]. Crabtree, Wandless and col- 
leagues [12] therefore attached pYEE1 to either FK506 
(FK-pYEE1) or a simpler synthetic FKBP ligand, known 
as SLF (SLF-pYEE1) [14]. The linker used was designed 
on the basis of the crystal structures of both the Fyn SK? 
domain and FKBP12 to optimize surface contact between 
the Fyn SHZ domain and FKBP. When the binding affni- 
ties between the two pYEEI-containing conjugates were 
measured in the absence or the presence of FKBP12 and 
FKBPSZ, some surprising observations were made. The 
presence of FKBP.52 enhanced the binding of FK-pYEEI 
to the Fyn SH2 domain by about threefold, whereas the 
presence of FKBP12 made little difference. In contrast, 
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Figure 1 
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Two opposite effects of a borrowed protein surface on small ligand- 
receptor interactions. (a) An enhanced interaction. (b) A weakened 
interaction. The ligand of interest is represented by a purple triangle 
and the borrowed ligand is represented by a pink circle. 
the addition of FKBP12 decreased the affinity of 
SLF-pYEE1 by almost sixfold, whereas addition of 
FKBP52 had little effect. Although the changes in affinity 
seem somewhat small, these are the results from the very 
first set of conjugates tested, without further optimization. 
The results therefore signal a new direction for the modi- 
fication of small ligands that may eventually be capable of 
efficiently modulating protein-protein interactions. 
Among the most important questions raised from this 
study are why and how the FK-pYEEI-FKBP52 complex 
had increased affinity for the Fyn SH2 domain, whereas 
the other complexes had either a decrease or no change in 
affinity. These differences are likely to be attributable to 
the protein-protein contacts between FKBP.52 and the 
Fyn SHZ domain, as the authors suggested [12]. A compar- 
ison of the structure of FK-pYEE1 with that of 
SLF-pYEE1 suggests another possibility; the portion of 
FK.506 that is missing in SLF in the calcineurin effector 
domain may also make fruitful contacts with residues in 
the SH2 domain. A cocrystal structure of the trimeric 
complex consisting of the Fyn SH2 domain, FK-pYEE1 
and FKBP52 will be quite informative, revealing the rela- 
tive contributions of various components of this complex 
to the enhanced affinity. The structure of the complex 
containing the Fyn SH2 domain, SLF-pYEE1 and 
FKBP12 could be equally revealing as to why this complex 
had little change in affinity. As for the decrease in affinity 
observed for the SLF-pYEEI-FKBP12 complex, it may 
be rationalized in large part by the difference in distance 
between the tetrapeptide and a-dicarbonylamide in 
FK506 or SLF. To a first approximation, the linker is 
about four atoms closer to the dicarbonyl pipcolinic ester 
in SLF-pYEE1 than in FK-pYEE1, thus bringing the Fyn 
SH2 domain closer to FKBP12, leading to steric clashes 
between the Fyn SH2 domain and FKBP12, and a 
decrease in affinity between Fyn SH2 and SLF-pYEE1. 
By converting a single ligand into a bifunctional dimer and 
using the attached ligand to recruit a presenting protein, 
the authors effectively transformed a simple, straightfor- 
ward small ligand-protein interaction into a more sophisti- 
cated trimolecular complex involving both ligand-protein 
and protein-protein interactions. Once the ligands are 
decided upon, the nature and length of the linker con- 
necting the two small ligands will determine the distance 
and orientation of the target protein with respect to the 
presenting protein. Crabtree, Wandless and colleagues 
[12] took advantage of the availability of the crystal struc- 
tures of the FKBP-FK506 complex and the Fyn SH2 
domain to design a linker that allowed a favorable inter- 
action between FKBP52 and the Fyn SH2 domain. For 
protein targets for which no crystal structural data is avail- 
able, one will have to take a trial-and-error approach by 
testing a number of possible candidates. 
In addition to FKBPs, quite a few other cellular proteins 
can also be borrowed to present dimeric ligands. For this 
approach to work in &NJ, however, the binding of the 
bifunctional ligand to the presenting protein per se should 
not interfere with other cellular processes. The heat-shock 
proteins, an abundant family of proteins, fit this criterion. 
The interactions of heat-shock proteins with small ligands 
do not usually have significant cellular consequences [15]. 
Although plasticity on protein surfaces allows presenting 
proteins and target proteins to find favorable interactions 
with one’ another, to what extent such interactions can 
‘occur between any two given proteins remain to be seen. 
One general approach to discovering suitable presenting 
proteins could involve using a library of ligands conjugated 
to pYEE1 in place of FK506 or SLF and screening in a cel- 
lular context for those that have higher affinity without 
even predetermining which proteins are recruited. Once 
such a ligand is discovered, the corresponding presenting 
protein can then be identified and characterized. 
In essence, the surface-borrowing approach is to create 
more than one point of contact to a given protein target, 
thereby enhancing or weakening the interaction between 
a ligand and its target protein (Figure 1). In principle, it is 
related to the use of secondary binding sites on proteins to 
produce new multimeric ligands that have higher affinity 
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for the target protein [16,17]. What is unique about the 
protein-leasing approach is that the presenting protein 
associated with the bifunctional l&and provides a much 
larger surface area than the surface area that can be pre- 
sented by individual small ligands alone. The approach 
extends the power of small ligands in biology and medi- 
cine [18]. The search for new synthetic dimeric ligands for 
controlling protein-protein interactions will provide new 
challenges, as well as opportunities, for chemists and biol- 
ogists for some time to come. 
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